Parsons Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-10,816
| Closed | -$76K | – | 416 |
|
|
2020
Q4 | $76K | Hold |
10,816
| – | – | 0.01% | 372 |
|
|
2020
Q3 | $88K | Hold |
10,816
| – | – | 0.01% | 346 |
|
|
2020
Q2 | $75K | Hold |
10,816
| – | – | 0.01% | 330 |
|
|
2020
Q1 | $51K | Hold |
10,816
| – | – | 0.01% | 310 |
|
|
2019
Q4 | $94K | Hold |
10,816
| – | – | 0.01% | 341 |
|
|
2019
Q3 | $36K | Hold |
10,816
| – | – | ﹤0.01% | 338 |
|
|
2019
Q2 | $54K | Hold |
10,816
| – | – | 0.01% | 345 |
|
|
2019
Q1 | $67K | Hold |
10,816
| – | – | 0.01% | 339 |
|
|
2018
Q4 | $36K | Hold |
10,816
| – | – | ﹤0.01% | 326 |
|
|
2018
Q3 | $70K | Hold |
10,816
| – | – | 0.01% | 350 |
|
|
2018
Q2 | $83K | Sell |
10,816
-200
| -2% | -$1.54K | 0.01% | 350 |
|
|
2018
Q1 | $246K | Sell |
11,016
-32,000
| -74% | -$715K | 0.03% | 326 |
|
|
2017
Q4 | $548K | Hold |
43,016
| – | – | 0.06% | 250 |
|
|
2017
Q3 | $670K | Buy |
+43,016
| New | +$670K | 0.08% | 215 |
|